Inhaler definition
Examples of Inhaler in a sentence
At the Closing, each Shareholder shall sell, transfer, convey, assign and deliver to Love Group its Lovego Holdings Shares free and clear of all Liens in exchange for the Love Group Stock listed on Annex A opposite such Shareholder’s name.
AeroGen shall use diligent efforts, consistent with its other shipment obligations and manufacturing capacity, to ship all Inhaler Products and Adapters for which purchase orders are accepted on or before the requested shipment date, to the extent such date is at least [*] after the date AeroGen accepts the purchase order for such shipment.
AeroGen shall use commercially reasonable efforts to develop the Clinical Test Inhaler, in accordance with the specifications set [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
In the event PathoGenesis intends to utilize the Clinical Test Inhaler, Inhaler, Adapter, Ampoule or any other [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
Upon AeroGen's reasonable request, PathoGenesis and AeroGen shall meet and confer regarding the regulatory requirements of such country, compliance therewith, the timeline for compliance, the costs associated with compliance and the manufacture of the Inhaler in compliance therewith.
Notwithstanding the foregoing, AeroGen (or its designee) shall have the right, upon reasonable written request, the granting of which is not to be unreasonably withheld, to use any data or information generated by PathoGenesis with respect to the performance characteristics of the Inhaler (the "Inhaler Data"), in connection with AeroGen's development and submission for regulatory approval and commercialization of, the AeroGen Inhaler, consistent with AeroGen's obligations under Section 2.
At the time of [*], the parties will mutually agree on a target manufacturing cost per unit (the "Target Cost") and consequent Inhaler Transfer Price.
In the event that the actual Target Cost exceeds the agreed upon Target Cost by [*] or more, then the Inhaler Markup shall be reduced by [*] for every [*] of such excess.
In the event that the actual Target Cost is below the agreed upon Target Cost by [*] or more, then the Inhaler Markup shall be increased by [*] for every [*] of such decrease.
Additionally, AeroGen shall develop the Inhaler: (i) in compliance with cGMP; and (ii) in accordance with AeroGen's internal quality control and product specifications or as otherwise agreed upon by AeroGen and PathoGenesis.